Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
about
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerEpithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancerCirculating tumor cells in breast cancerDynamic changes in numbers and properties of circulating tumor cells and their potential applicationsMinimal residual disease and circulating tumor cells in breast cancerCirculating tumor cells in the diagnosis and management of pancreatic cancerCirculating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical studyMultiphase ferrofluid flows for micro-particle focusing and separation.Circulating Tumor Cell Isolation and Analysis.Fundamentals and application of magnetic particles in cell isolation and enrichment: a reviewMicrofluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arraysMultiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.Novel tools for prostate cancer prognosis, diagnosis, and follow-upFlow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.Automated identification of circulating tumor cells by image cytometry.Analysis of circulating tumor cells in breast cancer.Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.Laser scanning cytometry: principles and applications-an update.Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionInsulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.Filter characteristics influencing circulating tumor cell enrichment from whole blood.Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience.The systematic study of circulating tumor cell isolation using lithographic microfiltersCirculating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor typeCirculating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancerPrognostic and Predictive Markers for Treatment Decisions in Early Breast CancerClinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticityEfficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinomaSynthesis and characterization of Her2-NLP peptide conjugates targeting circulating breast cancer cells: cellular uptake and localization by fluorescent microscopic imaging.Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.
P2860
Q21296854-D2F5BBFD-FF4F-406C-A8CF-E182284D54D6Q24606925-F82EF282-4514-47D7-8998-112E6176AC92Q26774808-1904524D-B677-4A3A-8338-33983CFC88EDQ26853569-186527BE-F29A-40E1-A392-7C24BB11766FQ27010152-6DB2D4B8-5837-4C5A-8432-1F2CC752D42DQ27027711-2781A21D-2682-478A-8F03-2378A19B6D30Q28535476-F14A6464-FCA0-475F-A2E1-75FBF4FDAD2BQ30357087-F297F381-D440-4A94-A173-A3FD1DD81AEBQ30358229-58D391C9-F1AE-4238-BE93-DC01A18C1782Q30395055-8B31E4B8-71F3-41FF-8BD7-20927D609453Q30496357-1678A907-EA9B-4F6B-8847-66C18054853DQ31006508-4CE6819E-77FF-469A-8D85-08F278CACFD4Q33559406-2C9E75D5-8C06-4A6A-8F7A-F7D3E16E88EAQ33625338-5656AE05-49B6-493A-8A66-C0A1560907DCQ33758219-6DC1F581-AB96-4942-B774-AAB56106024DQ33958981-3258A2C0-A6E0-48C5-8B86-E4DC7F695714Q34098110-E7C75B5B-9400-4094-AE7D-B0731A6E5CFEQ34101560-079B0981-C95B-4CCA-8BAB-0085B87EC051Q34156275-200E45B0-FB0A-481D-8E20-980EACB463F5Q34284264-C2976A3B-AE93-4C7A-986A-975DAD53D023Q34289862-33F7A6B9-A576-4731-A87C-951FFA5CE50CQ34425863-60AB9CBC-E199-4282-8103-49E281772D3CQ34496964-2AB411A6-2917-4584-A9E2-7D43EB213AE2Q34590296-353B0188-D87C-4192-AB25-784EF820605BQ34692322-D4E39F07-B1FF-49A3-B2C1-7A0205331B0FQ34779138-B89690CF-5651-45BE-9279-E6CB38FD9E49Q34796583-714B30FD-0BFE-4AC1-96DC-9041E646A6F6Q34807126-0B967C59-2C10-4945-B6AB-189D4559A686Q34987281-48F07E84-39FC-467E-83F2-44BF4A1062C2Q35000667-2516F052-0822-418B-912D-49320314FCA1Q35006907-F55435D7-A874-4350-ADDD-54DE30BF9C55Q35095603-BE5307FE-B337-40A2-A9C3-F03BBEC347D3Q35124176-0328E669-D549-4CE5-8838-C6E0DA2F4EF5Q35161280-014AEC88-C2C1-4F84-BDBB-234C8B6A285CQ35548992-4D551ACA-5F56-47AD-BD03-6B13C2160C40Q35558096-FE7190AC-9A1B-4911-B96B-DCBC5AAEF549Q35584126-95FDB457-BC55-4AFC-A1EF-F9303F08A79EQ35608699-1E3B7D1E-FDB3-40D8-A111-BDA6293F27BCQ35694837-2AB94136-0C92-4F89-A711-6575C9444016Q35735913-1539B0D4-B7D5-4EC5-B699-25DE54D8C5D0
P2860
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Monitoring the response of cir ...... ents at risk of early relapse.
@ast
Monitoring the response of cir ...... ents at risk of early relapse.
@en
Monitoring the response of cir ...... ents at risk of early relapse.
@nl
type
label
Monitoring the response of cir ...... ents at risk of early relapse.
@ast
Monitoring the response of cir ...... ents at risk of early relapse.
@en
Monitoring the response of cir ...... ents at risk of early relapse.
@nl
prefLabel
Monitoring the response of cir ...... ents at risk of early relapse.
@ast
Monitoring the response of cir ...... ents at risk of early relapse.
@en
Monitoring the response of cir ...... ents at risk of early relapse.
@nl
P2093
P356
P1476
Monitoring the response of cir ...... ents at risk of early relapse.
@en
P2093
Andreas Kavallaris
Annelore Altendorf-Hofmann
Carola Rabenstein
Cornelia Jörke
Ingo Runnebaum
Katharina Pachmann
Klaus Höffken
Mieczyslaw Gajda
Nele Malarski
Oumar Camara
P304
P356
10.1200/JCO.2007.13.6523
P407
P577
2008-03-01T00:00:00Z